Ayako Nagayama

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use

Yuka Goto, Yoshie Otsuka, Kenji Ashida et al. · Endocrine Connections · 2020 · 36 citations · Full text

An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion

Satoko Oda, Kenji Ashida, Makiko Uchiyama et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 30 citations · Full text

Identification of substances which regulate activity of corticotropin-releasing factor-producing neurons in the paraventricular nucleus of the hypothalamus

Yasutaka Mukai, Ayako Nagayama, Keiichi Itoi et al. · Scientific Reports · 2020 · 26 citations · Full text

Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury

Nao Hasuzawa, Keita Tatsushima, Lixiang Wang et al. · Scientific Reports · 2021 · 23 citations · Full text

Eruptive xanthomas as a marker for metabolic disorders: A specific form of xanthoma that reflects hypertriglyceridemia

Sohichiroh Ohtaki, Kenji Ashida, Yuko Matsuo et al. · Clinical Case Reports · 2022 · 19 citations · Full text

Specific Form, Metabolic Syndrome, Skin Manifestations +12